Largest biotechnology: pharmaceutical preparations companies — Page 2
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.231 T
5.3% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$10.462 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 101 | ADARx PharmaceuticalsADRX | $1.89B | $17.68 | +0.28% | United States |
| 102 | Maravai LifesciencesMRVI | $1.87B | $7.20 | +3.00% | United States |
| 103 | XencorXNCR | $1.85B | $24.94 | +7.55% | United States |
| 104 | SepternaSEPN | $1.84B | $39.35 | +8.16% | United States |
| 105 | Zenas BioPharmaZBIO | $1.84B | $28.18 | +5.50% | United States |
| 106 | Trevi TherapeuticsTRVI | $1.83B | $12.83 | +7.81% | United States |
| 107 | Braveheart BioBRVE | $1.83B | $20.27 | +5.52% | United States |
| 108 | Palvella TherapeuticsPVLA | $1.79B | $123.92 | +0.78% | United States |
| 109 | BiohavenBHVN | $1.78B | $11.81 | +4.05% | United States |
| 110 | SchrodingerSDGR | $1.75B | $23.40 | +1.21% | United States |
| 111 | Stoke TherapeuticsSTOK | $1.72B | $26.61 | +7.21% | United States |
| 112 | UroGen PharmaURGN | $1.71B | $35.01 | +2.52% | Israel |
| 113 | Nuvation BioNUVB | $1.67B | $4.77 | +6.47% | United States |
| 114 | Kailera TherapeuticsKLRA | $1.67B | $12.89 | +12.77% | United States |
| 115 | Ani PharmaceuticalsANIP | $1.67B | $72.67 | +0.15% | United States |
| 116 | Generate BiomedicinesGENB | $1.66B | $12.90 | +2.71% | United States |
| 117 | COMPASS PathwaysCMPS | $1.65B | $11.90 | +7.11% | United Kingdom |
| 118 | Structure TherapeuticsGPCR | $1.63B | $22.88 | +3.95% | United States |
| 119 | Ultragenyx PharmaceuticalRARE | $1.58B | $16.02 | +6.30% | United States |
| 120 | uniQureQURE | $1.58B | $22.72 | +2.32% | Netherlands |
| 121 | Phibro Animal HealthPAHC | $1.58B | $38.80 | -1.37% | United States |
| 122 | InnovivaINVA | $1.54B | $21.28 | +0.95% | United States |
| 123 | Ascentage Pharma Group InternationalAAPG | $1.49B | $15.92 | +3.65% | China |
| 124 | First Tracks BiotherapeuticsTRAX | $1.47B | $41.25 | +13.70% | United States |
| 125 | Ocular TherapeutixOCUL | $1.46B | $6.65 | +5.72% | United States |
| 126 | Pacira BioSciencesPCRX | $1.45B | $36.38 | +0.11% | United States |
| 127 | Eton PharmaceuticalsETON | $1.43B | $50.19 | +1.97% | United States |
| 128 | Oric PharmaceuticalsORIC | $1.43B | $13.78 | +8.33% | United States |
| 129 | Korsana BiosciencesKRSA | $1.41B | $31.03 | -1.21% | United States |
| 130 | Rapport TherapeuticsRAPP | $1.41B | $29.37 | +2.69% | United States |
| 131 | Tyra BiosciencesTYRA | $1.41B | $20.47 | +5.84% | United States |
| 132 | AnaptysbioANAB | $1.35B | $45.43 | -7.74% | United States |
| 133 | Nektar TherapeuticsNKTR | $1.34B | $39.22 | +7.04% | United States |
| 134 | Lb PharmaceuticalsLBRX | $1.32B | $41.00 | +5.64% | United States |
| 135 | GH ResearchGHRS | $1.31B | $19.17 | +4.84% | Ireland |
| 136 | Damora TherapeuticsDMRA | $1.28B | $20.67 | +7.26% | Denmark |
| 137 | KardiganKARD | $1.26B | $13.51 | +4.41% | United States |
| 138 | Opko HealthOPK | $1.24B | $1.66 | +3.11% | United States |
| 139 | NanobiotixNBTX | $1.23B | $24.14 | +14.52% | France |
| 140 | Silence TherapeuticsSLN | $1.22B | $19.61 | +0.15% | United Kingdom |
| 141 | Bicara TherapeuticsBCAX | $1.21B | $18.35 | +5.04% | United States |
| 142 | OmerosOMER | $1.20B | $16.55 | +1.22% | United States |
| 143 | Syndax PharmaceuticalsSNDX | $1.18B | $13.25 | +1.22% | United States |
| 144 | VerastemVSTM | $1.13B | $9.34 | +8.35% | United States |
| 145 | Amphastar PharmaceuticalsAMPH | $1.10B | $25.94 | -0.77% | United States |
| 146 | Avalyn PharmaAVLN | $1.09B | $24.63 | +5.57% | United States |
| 147 | HarrowHROW | $1.05B | $28.07 | +1.41% | United States |
| 148 | Janux TherapeuticsJANX | $1.05B | $17.20 | +2.75% | United States |
| 149 | City TherapeuticsCTY | $1.05B | $20.83 | -2.94% | United States |
| 150 | Seaport TherapeuticsSPTX | $1.03B | $19.28 | +8.38% | United States |
| 151 | Latigo BiotherapeuticsLTGO | $1.01B | $15.25 | +6.64% | United States |
| 152 | MannkindMNKD | $996.8M | $3.10 | +0.32% | United States |
| 153 | SavaraSVRA | $978.0M | $4.76 | +2.81% | United States |
| 154 | Alto NeuroscienceANRO | $957.9M | $24.41 | +6.97% | United States |
| 155 | Jade BiosciencesJBIO | $945.1M | $14.86 | +7.45% | United States |
| 156 | ArriVent BioPharmaAVBP | $929.5M | $18.85 | +5.07% | United States |
| 157 | Rigel PharmaceuticalsRIGL | $898.7M | $48.11 | +2.98% | United States |
| 158 | Aktis OncologyAKTS | $894.4M | $16.08 | +6.42% | United States |
| 159 | Kura OncologyKURA | $887.8M | $9.98 | +6.62% | United States |
| 160 | CryoportCYRX | $883.3M | $17.44 | +2.71% | United States |
| 161 | MoonLake ImmunotherapeuticsMLTX | $878.3M | $10.32 | +5.85% | United States |
| 162 | AlumisALMS | $867.2M | $6.70 | +5.68% | United States |
| 163 | Corvus PharmaceuticalsCRVS | $860.6M | $10.23 | +6.01% | United States |
| 164 | Obsidian TherapeuticsOBX | $818.5M | $13.25 | +10.97% | United States |
| 165 | ArdelyxARDX | $799.9M | $3.21 | +3.88% | United States |
| 166 | Helus PharmaHELP | $799.3M | $10.94 | +2.34% | Canada |
| 167 | GeronGERN | $796.7M | $1.24 | +3.33% | United States |
| 168 | ApnimedAPMD | $770.6M | $18.51 | +11.54% | United States |
| 169 | InventivaIVA | $770.3M | $3.26 | +9.40% | France |
| 170 | Collegium PharmaceuticalCOLL | $756.3M | $23.23 | +0.96% | United States |
| 171 | Immix BiopharmaIMMX | $738.7M | $8.91 | +8.39% | United States |
| 172 | AnnexonANNX | $726.1M | $3.83 | -4.49% | United States |
| 173 | Lexicon PharmaceuticalsLXRX | $703.0M | $1.58 | +1.93% | United States |
| 174 | Design TherapeuticsDSGN | $694.7M | $11.10 | +4.32% | United States |
| 175 | Pharming GroupPHAR | $688.6M | $9.75 | +7.03% | Netherlands |
| 176 | Gyre TherapeuticsGYRE | $688.0M | $6.17 | +1.31% | United States |
| 177 | Sagimet BiosciencesSGMT | $687.0M | $9.74 | +9.93% | United States |
| 178 | Adlai Nortye GroupANL | $685.2M | $10.64 | +2.50% | Cayman Islands |
| 179 | Wave Life SciencesWVE | $674.5M | $3.42 | +7.89% | Singapore |
| 180 | Nuvectis PharmaNVCT | $671.5M | $20.59 | +8.71% | United States |
| 181 | Arbutus BiopharmaABUS | $663.7M | $4.33 | +2.36% | Canada |
| 182 | Avalo TherapeuticsAVTX | $662.9M | $12.36 | +6.64% | United States |
| 183 | Olema PharmaceuticalsOLMA | $634.4M | $7.25 | +1.97% | United States |
| 184 | Zevra TherapeuticsZVRA | $621.7M | $10.47 | +3.05% | United States |
| 185 | Climb BioCLYM | $620.3M | $10.80 | +11.00% | United States |
| 186 | Ironwood PharmaceuticalsIRWD | $599.8M | $3.63 | +1.97% | United States |
| 187 | Phathom PharmaceuticalsPHAT | $591.4M | $7.31 | +4.28% | United States |
| 188 | CorMedixCRMD | $590.0M | $7.57 | +2.58% | United States |
| 189 | Shattuck LabsSTTK | $586.1M | $5.84 | +8.75% | United States |
| 190 | Puma BiotechnologyPBYI | $555.4M | $10.76 | +5.39% | United States |
| 191 | Aclaris TherapeuticsACRS | $554.9M | $3.77 | +8.33% | United States |
| 192 | CytomX TherapeuticsCTMX | $546.9M | $2.51 | +7.26% | United States |
| 193 | Bright Minds BiosciencesDRUG | $542.0M | $55.20 | +2.56% | Canada |
| 194 | Faeth TherapeuticsFTH | $537.2M | $20.79 | +6.94% | United States |
| 195 | MapLight TherapeuticsMPLT | $533.7M | $8.24 | +3.00% | United States |
| 196 | Evotec SEEVO | $526.5M | $1.48 | +4.22% | Germany |
| 197 | Aquestive TherapeuticsAQST | $508.3M | $4.05 | +5.74% | United States |
| 198 | NeurogeneNGNE | $508.3M | $25.40 | +5.09% | Canada |
| 199 | ArvinasARVN | $500.9M | $7.66 | +5.51% | United States |
| 200 | Monopar TherapeuticsMNPR | $498.2M | $74.23 | +3.86% | United States |
Showing 101–200 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 22 Oct 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 233Computer Manufacturing 10Major Banks 243Industrial Machinery/Components 210Catalog/Specialty Distribution 30Business Services 92Commercial Banks 35Integrated oil Companies 16Auto Manufacturing 29Oil & Gas Production 116Department/Specialty Retail Stores 13Investment Bankers/Brokers/Service 69Real Estate Investment Trusts 175Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 165Electronic Components 20Biotechnology: Biological Products (No Diagnostic Substances) 162Medical Specialities 44Consumer Electronics/Appliances 23Package Goods/Cosmetics 24All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.